ACTG Publications

TitleAuthorsDateJournalIssueVolume
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.Tashima, Karen T ; Mollan, Katie R ; Na, Lumine ; Gandhi, Rajesh T ; Klingman, Karin L ; Fichtenbaum, Carl J ; Andrade, Adriana ; Johnson, Victoria A ; Eron, Joseph J ; Smeaton, Laura ; Haubrich, Richard H2015 AugHIV Clin Trials416
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Tashima, Karen T ; Smeaton, Laura M ; Fichtenbaum, Carl J ; Andrade, Adriana ; Eron, Joseph J ; Gandhi, Rajesh T ; Johnson, Victoria A ; Klingman, Karin L ; Ritz, Justin ; Hodder, Sally ; Santana, Jorge L ; Wilkin, Timothy ; Haubrich, Richard H ; A5241 Study Team2015 Dec 15Ann Intern Med12163
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.Hogan, Christine M ; Degruttola, Victor ; Sun, Xin ; Fiscus, Susan A ; Del Rio, Carlos ; Hare, C Bradley ; Markowitz, Martin ; Connick, Elizabeth ; Macatangay, Bernard ; Tashima, Karen T ; Kallungal, Beatrice ; Camp, Rob ; Morton, Tia ; Daar, Eric S ; Little, Susan ; A5217 Study Team2012 Jan 1J Infect Dis1205
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.Taylor, Lynn E ; Holubar, Marisa ; Wu, Kunling ; Bosch, Ronald J ; Wyles, David L ; Davis, John A ; Mayer, Kenneth H ; Sherman, Kenneth E ; Tashima, Karen T2011 Mar 15Clin Infect Dis652
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Shikuma, Cecilia M ; Ribaudo, Heather J ; Zheng, Yu ; Gulick, Roy M ; Meyer, William A ; Tashima, Karen T ; Bastow, Barbara ; Kuritzkes, Daniel R ; Glesby, Marshall J ; AIDS Clinical Trials Group A5095 Study Team2011 MayAIDS Res Hum Retroviruses527
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.Riddler, Sharon A ; Jiang, Hongyu ; Tenorio, Allan ; Huang, Hairong ; Kuritzkes, Daniel R ; Acosta, Edward P ; Landay, Alan ; Bastow, Barbara ; Haas, David W ; Tashima, Karen T ; Jain, Mamta K ; Deeks, Steven G ; Bartlett, John A2007Antivir Ther412
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).Shikuma, Cecilia M ; Yang, Yang ; Glesby, Marshall J ; Meyer, William A ; Tashima, Karen T ; Ribaudo, Heather J ; Webb, Nancy ; Bastow, Barbara ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Apr 15J Acquir Immune Defic Syndr544
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Ribaudo, Heather J ; Haas, David W ; Tierney, Camlin ; Kim, Richard B ; Wilkinson, Grant R ; Gulick, Roy M ; Clifford, David B ; Marzolini, Catia ; Fletcher, Courtney V ; Tashima, Karen T ; Kuritzkes, Daniel R ; Acosta, Edward P ; Adult AIDS Clinical Trials Group Study2006 Feb 1Clin Infect Dis342